Skip to main content
Figure 3 | Annals of General Psychiatry

Figure 3

From: Maintenance therapy with once-monthly administration of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder: a pilot study of an extended dosing interval

Figure 3

Mean (± SD) plasma concentrations of risperidone plus 9-hydroxyrisperidone by study week. Pharmacokinetic (PK) analyses are based on 771 samples from 87 patients. Intensive pharmacokinetic data are based on 7 samples planned between weeks 24 and 28 (1 every 4 days) from 18 patients.

Back to article page